Longarone, 7 March 2019 – De Rigo Vision celebrates the women that work in the company and an important action to help prevent breast cancer on their special day.
The project is part of a programme to help improve the personal life of De Rigo employees who can access the prevention activity at the company premises and during working hours, without having to give up free time that is already very busy.
Implemented in partnership with the "Amiche per la pelle" onlus association, the initiative will start in July with the presence of the Pink Camper for prevention screening at the De Rigo Vision factory. It will be offered in an initial phase to women aged 40-50 years. This age group is not as yet included in the free national prevention programme but according to the association data is one in which breast cancer is particularly prevalent. This is a delicate life phase in which women have to address work and family commitments that are still very pressing and devote more time to others rather than themselves.
Developed in partnership with union organisations and RSU (the amalgamated union), the initiative has been financed by Regione Veneto to support welfare and work-life balance projects. It is part of "smart working", an area in which De Rigo will actively work in addition to 3 others:
Beniamina Rosset and Pino Olivotti, coordinators of the RSUs for De Rigo Vision commented, “We are completely satisfied to note that the work-life projects are highly desired and we hope that a little of this experience will be addressed in company negotiation in the future”.
Barbara De Rigo, Director of Marketing House Brands and De Rigo Vision Corporate Communication commented, “Our company is one is which females prevail: women account for more than 65% of the workforce and more than 80% in certain divisions. As a family and a company and from a personal point of view we want to offer our employees the chance to undertake a free screening at the company and during working hours so that they do not put off such an important visit for the prevention and treatment of breast cancer”.